CHARLES SCHWAB INVESTMENT MANAGEMENT INC - GRITSTONE ONCOLOGY INC ownership

GRITSTONE ONCOLOGY INC's ticker is GRTS and the CUSIP is 39868T105. A total of 73 filers reported holding GRITSTONE ONCOLOGY INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
CHARLES SCHWAB INVESTMENT MANAGEMENT INC ownership history of GRITSTONE ONCOLOGY INC
ValueSharesWeighting
Q3 2023$345,101
-24.6%
200,640
-14.5%
0.00%
Q2 2023$457,566
+384.0%
234,649
+590.0%
0.00%
Q1 2023$94,545
-19.4%
34,0090.0%0.00%
Q4 2022$117,331
+113.3%
34,009
+58.9%
0.00%
Q3 2022$55,000
+5.8%
21,4000.0%0.00%
Q2 2022$52,000
-89.1%
21,400
-81.4%
0.00%
Q1 2022$476,000
-67.5%
115,346
+1.2%
0.00%
Q4 2021$1,466,000
+32.5%
113,987
+11.3%
0.00%
Q3 2021$1,106,000
-32.5%
102,370
-42.9%
0.00%
-100.0%
Q2 2021$1,638,000
+11.9%
179,321
+15.6%
0.00%0.0%
Q1 2021$1,464,000
+162.4%
155,164
+9.6%
0.00%
Q4 2020$558,000
+50.8%
141,511
+1.4%
0.00%
Q3 2020$370,000
-61.5%
139,536
-3.6%
0.00%
Q2 2020$962,000
+31.8%
144,743
+15.5%
0.00%
Q1 2020$730,000
-34.1%
125,282
+1.4%
0.00%
-100.0%
Q4 2019$1,108,000
+4.9%
123,509
+1.0%
0.00%0.0%
Q3 2019$1,056,000
-21.5%
122,252
+1.2%
0.00%0.0%
Q2 2019$1,346,000
+156.9%
120,787
+207.0%
0.00%
Q1 2019$524,000
-12.5%
39,343
+1.6%
0.00%
Q4 2018$599,00038,7110.00%
Other shareholders
GRITSTONE ONCOLOGY INC shareholders Q4 2020
NameSharesValueWeighting ↓
Versant Venture Management, LLC 3,102,929$18,059,047,0004.95%
Svennilson Peter 3,102,934$18,059,0002.29%
Casdin Capital, LLC 2,270,000$13,211,0001.40%
FRAZIER MANAGEMENT LLC 2,061,758$11,999,0001.36%
Redmile Group, LLC 3,068,194$17,857,0000.50%
Alphabet Inc. 929,022$5,407,0000.36%
Bleichroeder LP 169,039$984,0000.26%
Leap Investments LP 14,400$84,0000.12%
DAFNA Capital Management LLC 50,000$291,0000.12%
Blackstone Inc. 2,567,445$14,943,0000.11%
View complete list of GRITSTONE ONCOLOGY INC shareholders